2021
DOI: 10.1080/01635581.2021.1973518
|View full text |Cite
|
Sign up to set email alerts
|

Folate Intake and Risk of Urothelial Carcinoma: A Systematic Review and Meta-Analysis of Epidemiological Studies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 70 publications
0
2
0
Order By: Relevance
“…( 2016 ) Incident endometrial cancer Folate intake PCs, NCCs, CCs PubMed, Embase and Web of Science Search date NR 5 PCs OR (highest vs. lowest) = 1.05, 95% CI: 0.90–1.20; I 2 = 19.8% Positive association for type II but not type I endometrial cancer in one study (OR Q4 vs. Q1 1.71 (0.87, 3.36), Q4 > 560 vs. Q1 < 250 μg/day total folate) (Uccella et al., 2011 ); null or negative associations in other studies Gu et al. ( 2022 ) Urothelial carcinoma Folate intake and P/S folate PCs, NCCs, CCs Pubmed and eMBASe databases Until October 2019 8 PCs +2 NCCs [9 assessed dietary folate intake and 1 plasma folate] RR (highest vs. lowest) = 0.97, 95% CI: 0.87–1.09, p = 0.638; I 2 0% Positive associations in two studies (Bassett et al., 2019 ) (RR Q5 vs. Q1 1.27, 95% CI 0.81, 2.00; <9.3 vs. >17.0 nmol/L) and (Michaud et al., 2002 ) (RR Q5 vs. Q1 1.16, 95% CI 0.82, 1.64; median Q1 257.3 vs. Q5 400.2 μg/day natural folate); null or negative associations in other studies Hezaveh et al. ( 2021 ) Incidence of non‐melanoma skin cancer (BCC, SCC or both) or overall skin cancer Folate intake Cohort studies and CCs Scopus, ISI Web of Science and PubMed From 2000 to July 2021 4 PCs Not pooled (few studies and heterogeneous) Positive association in two studies with BCC risk (RR positive in all quintiles vs. Q1 < 284 μg/day total folate, RR Q5 vs. Q1 1.19, 95% CI 1.01, 1.40 (van Dam et al., 2000 ); positive in all quintiles versus Q1, median Q1 208 μg/day total folate, RR Q5 vs. Q1 : 1.2 95% CI:1.1–1.3 (Fung et al.…”
Section: Flow Chart For the Selection Of Studies On Dose–response For...mentioning
confidence: 95%
“…( 2016 ) Incident endometrial cancer Folate intake PCs, NCCs, CCs PubMed, Embase and Web of Science Search date NR 5 PCs OR (highest vs. lowest) = 1.05, 95% CI: 0.90–1.20; I 2 = 19.8% Positive association for type II but not type I endometrial cancer in one study (OR Q4 vs. Q1 1.71 (0.87, 3.36), Q4 > 560 vs. Q1 < 250 μg/day total folate) (Uccella et al., 2011 ); null or negative associations in other studies Gu et al. ( 2022 ) Urothelial carcinoma Folate intake and P/S folate PCs, NCCs, CCs Pubmed and eMBASe databases Until October 2019 8 PCs +2 NCCs [9 assessed dietary folate intake and 1 plasma folate] RR (highest vs. lowest) = 0.97, 95% CI: 0.87–1.09, p = 0.638; I 2 0% Positive associations in two studies (Bassett et al., 2019 ) (RR Q5 vs. Q1 1.27, 95% CI 0.81, 2.00; <9.3 vs. >17.0 nmol/L) and (Michaud et al., 2002 ) (RR Q5 vs. Q1 1.16, 95% CI 0.82, 1.64; median Q1 257.3 vs. Q5 400.2 μg/day natural folate); null or negative associations in other studies Hezaveh et al. ( 2021 ) Incidence of non‐melanoma skin cancer (BCC, SCC or both) or overall skin cancer Folate intake Cohort studies and CCs Scopus, ISI Web of Science and PubMed From 2000 to July 2021 4 PCs Not pooled (few studies and heterogeneous) Positive association in two studies with BCC risk (RR positive in all quintiles vs. Q1 < 284 μg/day total folate, RR Q5 vs. Q1 1.19, 95% CI 1.01, 1.40 (van Dam et al., 2000 ); positive in all quintiles versus Q1, median Q1 208 μg/day total folate, RR Q5 vs. Q1 : 1.2 95% CI:1.1–1.3 (Fung et al.…”
Section: Flow Chart For the Selection Of Studies On Dose–response For...mentioning
confidence: 95%
“…The association of folate intake with the incidence of non-CRC cancers is inconsistent and was reviewed in detail elsewhere [141]. Higher intake of folate was associated with a reduced risk of squamous cell carcinoma of the head and neck [142] and esophageal [143][144][145], oral [146], pancreatic [147,148], and bladder cancers [149,150]. We should note that the higher intake in these studies was unlikely to represent excess folate intake and the analysis was not stratified to isolate the effects of intake that approach or exceed the UL.…”
Section: Folate Intake Association With Other Cancers and Overall Can...mentioning
confidence: 99%